Hologic Inc. (NASDAQ:HOLX) saw a downside of -0.17% to close Tuesday at $69.83 after subtracting -$0.12 on the day. The 5-day average trading volume is 1,432,280 shares of the company’s common stock. It has gained $72.64 in the past week. An average of 1,464,690 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,412,288.
HOLX’s 1-month performance is -11.04% or -$10.16 on its low of $69.74 reached on 10/12/21. The company’s shares have touched a 52-week low of $60.10 and high of $85.00, with the stock’s rally to the 52-week high happening on 02/16/21. YTD, HOLX has lost -4.12% or -$3.00. However, the current price is down -17.85%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Aug 10, 64 days have gone by since the last insider trading activity for Hologic Inc. (HOLX). COHN BENJAMIN JORDAN (Principal Accounting Officer) most recently sold 5,000 shares at $77.48 per share on Aug 10. This transaction cost the insider $387,425. General Counsel, Griffin John M., sold 26,683 shares at a price of $75.62 on Aug 09. Then, on May 10, Group President, BSH & Surg. Daugherty Sean S. sold 4,001 shares at a price of $65.02 per share. This transaction amounted to $260,149.
The company’s PE ratio for the last five years has touched a high of 59.40 and a low of 8.302. HOLX stock has a beta of 1.16. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 3.14 while the price-to-book (PB) in the most recent quarter is 4.62, with the price to cash flow ratio at 7.90.
Hologic Inc.’s quick ratio for the period ended June 29 was 1.30, with the current ratio over the same period at 1.70 meaning that HOLX stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.69, while the total debt to equity was 0.81. In terms of profitability, the gross margin trailing 12 months is 68.90%. The trailing 12-month EBITDA margin is 40.42% while for the period ending June 29; Hologic Inc.’s operating margin was 46.80%. The firm’s gross profit as reported stood at $2.23 billion against revenue of $3.78 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected HOLX to announce $1.12 per share in earnings in its latest quarter, but it posted $1.33, representing a 18.70% surprise. EBITDA for the quarter stood at more than $459.7 million. HOLX stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 4.71 billion, with total debt at $3.16 billion. Shareholders hold equity totaling $253.49 million
Let’s look briefly at Hologic Inc. (HOLX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 25.36% to suggest the stock is trending oversold, with historical volatility in this time period at 18.04%.
The stock’s 5-day moving average is $70.84, reflecting a -0.68% or -$0.48 change from its current price. HOLX is currently trading -10.53% above its 20-day SMA, +10.84% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -7.91% and -6.61% respectively.
Stochastic %K and %D was 6.98% and 13.44% and the average true range (ATR) pointed at 1.58. The RSI (14) points at 29.10%, while the 14-day stochastic is at 1.09% with the period’s ATR at 1.57. The stock’s 9-day MACD Oscillator is pointing at -0.87 and -2.19 on the 14-day charts.
In the most recent analyst report for Hologic Inc. (NASDAQ: HOLX), Evercore ISI upgraded it to an Outperform rating. They previously had an In-line rating on the stock. Analysts offering their rating for HOLX stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate HOLX as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 12 have offered a “buy” rating.
What is HOLX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $75.00 and a high of $95.00, with their median price target at $85.00. Looking at these predictions, the average price target given by analysts is for Hologic Inc. (HOLX) stock is $85.91.